Cargando…

A Nomogram Based on Hematological Parameters and Clinicopathological Characteristics for Predicting Local–Regional Recurrence After Breast-Conserving Therapy

OBJECTIVES: The aim of this study was to identify the factors for local–regional recurrence (LRR) after breast-conserving therapy (BCT). We established a practical nomogram to predict the likelihood of LRR after BCT based on hematological parameters and clinicopathological features. METHODS: A retro...

Descripción completa

Detalles Bibliográficos
Autores principales: Sun, Luhao, Zhao, Wei, Wang, Fukai, Song, Xiang, Wang, Xinzhao, Li, Chao, Yu, Zhiyong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9344968/
https://www.ncbi.nlm.nih.gov/pubmed/35928880
http://dx.doi.org/10.3389/fonc.2022.861210
_version_ 1784761329135910912
author Sun, Luhao
Zhao, Wei
Wang, Fukai
Song, Xiang
Wang, Xinzhao
Li, Chao
Yu, Zhiyong
author_facet Sun, Luhao
Zhao, Wei
Wang, Fukai
Song, Xiang
Wang, Xinzhao
Li, Chao
Yu, Zhiyong
author_sort Sun, Luhao
collection PubMed
description OBJECTIVES: The aim of this study was to identify the factors for local–regional recurrence (LRR) after breast-conserving therapy (BCT). We established a practical nomogram to predict the likelihood of LRR after BCT based on hematological parameters and clinicopathological features. METHODS: A retrospective analysis was performed on 2,085 consecutive breast cancer patients who received BCT in Shandong Cancer Hospital from 2006 to 2016, including 1,460 patients in the training cohort and 625 patients in the validation cohort. Univariate and multivariate analyses were performed based on hematological parameters (fibrinogen, platelets, mean platelet volume, neutrophils, monocytes, and lymphocytes) and clinicopathological characteristics to identify the independent factors for LRR. Subsequently, a nomogram for predicting LRR was established by logistic regression analysis. The nomogram was validated in 625 patients in the validation cohort. RESULTS: During the median follow-up period of 66 months, 44 (3.01%) patients in the training cohort and 19 (3.04%) patients in the validation cohort suffered from LRR. Multivariate analysis showed six independent factors related to LRR, including molecular subtype, pathological N stage, re-resection, radiotherapy or not, platelet count*MPV*fibrinogen (PMF), and neutrophil count/lymphocyte count ratio (NLR). Six variables were entered into logistic regression to establish the nomogram for predicting LRR. The nomogram of LRR showed excellent discrimination and prediction accuracy. The area under the receiver operating characteristic curve (AUC) was 0.89 (p < 0.001, 95% CI = 0.83, 0.95) in the training cohort and 0.88 (p < 0.001, 95% CI = 0.8, 0.96) in the validation cohort. Calibration curves for the prediction model in the training and validation cohorts both demonstrated satisfactory consistency between the nomogram-predicted and actual LRR. CONCLUSION: The combination of hematological parameters and clinicopathological characteristics can predict LRR after BCT. The predictive nomogram based on preoperative and postoperative indicators of BCT might serve as a practical tool for individualized prognostication. More prospective studies should be performed to verify the model.
format Online
Article
Text
id pubmed-9344968
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-93449682022-08-03 A Nomogram Based on Hematological Parameters and Clinicopathological Characteristics for Predicting Local–Regional Recurrence After Breast-Conserving Therapy Sun, Luhao Zhao, Wei Wang, Fukai Song, Xiang Wang, Xinzhao Li, Chao Yu, Zhiyong Front Oncol Oncology OBJECTIVES: The aim of this study was to identify the factors for local–regional recurrence (LRR) after breast-conserving therapy (BCT). We established a practical nomogram to predict the likelihood of LRR after BCT based on hematological parameters and clinicopathological features. METHODS: A retrospective analysis was performed on 2,085 consecutive breast cancer patients who received BCT in Shandong Cancer Hospital from 2006 to 2016, including 1,460 patients in the training cohort and 625 patients in the validation cohort. Univariate and multivariate analyses were performed based on hematological parameters (fibrinogen, platelets, mean platelet volume, neutrophils, monocytes, and lymphocytes) and clinicopathological characteristics to identify the independent factors for LRR. Subsequently, a nomogram for predicting LRR was established by logistic regression analysis. The nomogram was validated in 625 patients in the validation cohort. RESULTS: During the median follow-up period of 66 months, 44 (3.01%) patients in the training cohort and 19 (3.04%) patients in the validation cohort suffered from LRR. Multivariate analysis showed six independent factors related to LRR, including molecular subtype, pathological N stage, re-resection, radiotherapy or not, platelet count*MPV*fibrinogen (PMF), and neutrophil count/lymphocyte count ratio (NLR). Six variables were entered into logistic regression to establish the nomogram for predicting LRR. The nomogram of LRR showed excellent discrimination and prediction accuracy. The area under the receiver operating characteristic curve (AUC) was 0.89 (p < 0.001, 95% CI = 0.83, 0.95) in the training cohort and 0.88 (p < 0.001, 95% CI = 0.8, 0.96) in the validation cohort. Calibration curves for the prediction model in the training and validation cohorts both demonstrated satisfactory consistency between the nomogram-predicted and actual LRR. CONCLUSION: The combination of hematological parameters and clinicopathological characteristics can predict LRR after BCT. The predictive nomogram based on preoperative and postoperative indicators of BCT might serve as a practical tool for individualized prognostication. More prospective studies should be performed to verify the model. Frontiers Media S.A. 2022-07-19 /pmc/articles/PMC9344968/ /pubmed/35928880 http://dx.doi.org/10.3389/fonc.2022.861210 Text en Copyright © 2022 Sun, Zhao, Wang, Song, Wang, Li and Yu https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Oncology
Sun, Luhao
Zhao, Wei
Wang, Fukai
Song, Xiang
Wang, Xinzhao
Li, Chao
Yu, Zhiyong
A Nomogram Based on Hematological Parameters and Clinicopathological Characteristics for Predicting Local–Regional Recurrence After Breast-Conserving Therapy
title A Nomogram Based on Hematological Parameters and Clinicopathological Characteristics for Predicting Local–Regional Recurrence After Breast-Conserving Therapy
title_full A Nomogram Based on Hematological Parameters and Clinicopathological Characteristics for Predicting Local–Regional Recurrence After Breast-Conserving Therapy
title_fullStr A Nomogram Based on Hematological Parameters and Clinicopathological Characteristics for Predicting Local–Regional Recurrence After Breast-Conserving Therapy
title_full_unstemmed A Nomogram Based on Hematological Parameters and Clinicopathological Characteristics for Predicting Local–Regional Recurrence After Breast-Conserving Therapy
title_short A Nomogram Based on Hematological Parameters and Clinicopathological Characteristics for Predicting Local–Regional Recurrence After Breast-Conserving Therapy
title_sort nomogram based on hematological parameters and clinicopathological characteristics for predicting local–regional recurrence after breast-conserving therapy
topic Oncology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9344968/
https://www.ncbi.nlm.nih.gov/pubmed/35928880
http://dx.doi.org/10.3389/fonc.2022.861210
work_keys_str_mv AT sunluhao anomogrambasedonhematologicalparametersandclinicopathologicalcharacteristicsforpredictinglocalregionalrecurrenceafterbreastconservingtherapy
AT zhaowei anomogrambasedonhematologicalparametersandclinicopathologicalcharacteristicsforpredictinglocalregionalrecurrenceafterbreastconservingtherapy
AT wangfukai anomogrambasedonhematologicalparametersandclinicopathologicalcharacteristicsforpredictinglocalregionalrecurrenceafterbreastconservingtherapy
AT songxiang anomogrambasedonhematologicalparametersandclinicopathologicalcharacteristicsforpredictinglocalregionalrecurrenceafterbreastconservingtherapy
AT wangxinzhao anomogrambasedonhematologicalparametersandclinicopathologicalcharacteristicsforpredictinglocalregionalrecurrenceafterbreastconservingtherapy
AT lichao anomogrambasedonhematologicalparametersandclinicopathologicalcharacteristicsforpredictinglocalregionalrecurrenceafterbreastconservingtherapy
AT yuzhiyong anomogrambasedonhematologicalparametersandclinicopathologicalcharacteristicsforpredictinglocalregionalrecurrenceafterbreastconservingtherapy
AT sunluhao nomogrambasedonhematologicalparametersandclinicopathologicalcharacteristicsforpredictinglocalregionalrecurrenceafterbreastconservingtherapy
AT zhaowei nomogrambasedonhematologicalparametersandclinicopathologicalcharacteristicsforpredictinglocalregionalrecurrenceafterbreastconservingtherapy
AT wangfukai nomogrambasedonhematologicalparametersandclinicopathologicalcharacteristicsforpredictinglocalregionalrecurrenceafterbreastconservingtherapy
AT songxiang nomogrambasedonhematologicalparametersandclinicopathologicalcharacteristicsforpredictinglocalregionalrecurrenceafterbreastconservingtherapy
AT wangxinzhao nomogrambasedonhematologicalparametersandclinicopathologicalcharacteristicsforpredictinglocalregionalrecurrenceafterbreastconservingtherapy
AT lichao nomogrambasedonhematologicalparametersandclinicopathologicalcharacteristicsforpredictinglocalregionalrecurrenceafterbreastconservingtherapy
AT yuzhiyong nomogrambasedonhematologicalparametersandclinicopathologicalcharacteristicsforpredictinglocalregionalrecurrenceafterbreastconservingtherapy